ITGAM and neoplasm: The splenic CD11b+ MDSCs from tumor-bearing mice were isolated, treated with inhibitors of glycolysis (Supplementary Figure 3A) ex vivo and then added to splenocytes from Balb/c mice stimulated with anti-CD3/CD28 antibodies.